360 related articles for article (PubMed ID: 16511548)
1. Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide.
Pasricha PJ; Pehlivanov N; Sugumar A; Jankovic J
Nat Clin Pract Gastroenterol Hepatol; 2006 Mar; 3(3):138-48. PubMed ID: 16511548
[TBL] [Abstract][Full Text] [Related]
2. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
Patterson D; Abell T; Rothstein R; Koch K; Barnett J
Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
[TBL] [Abstract][Full Text] [Related]
3. Clinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parameters.
Parkman HP; Mishra A; Jacobs M; Pathikonda M; Sachdeva P; Gaughan J; Krynetskiy E
J Clin Gastroenterol; 2012 Jul; 46(6):494-503. PubMed ID: 22688145
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
Ganzini L; Casey DE; Hoffman WF; McCall AL
Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
[TBL] [Abstract][Full Text] [Related]
5. The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits.
Ehrenpreis ED; Deepak P; Sifuentes H; Devi R; Du H; Leikin JB
Am J Gastroenterol; 2013 Jun; 108(6):866-72. PubMed ID: 23735907
[TBL] [Abstract][Full Text] [Related]
6. Diabetic gastroparesis.
Tarsy D
N Engl J Med; 2007 Jul; 357(4):419; author reply 419-20. PubMed ID: 17663032
[No Abstract] [Full Text] [Related]
7. Acute chorea associated with metoclopramide use.
Dubow JS; Leikin J; Rezak M
Am J Ther; 2006; 13(6):543-4. PubMed ID: 17122536
[TBL] [Abstract][Full Text] [Related]
8. Warnings on metoclopramide treatment.
Bernstein R
Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1138; author reply 1138-9. PubMed ID: 19426834
[No Abstract] [Full Text] [Related]
9. Metoclopramide for the treatment of diabetic gastroparesis.
Shakhatreh M; Jehangir A; Malik Z; Parkman HP
Expert Rev Gastroenterol Hepatol; 2019 Aug; 13(8):711-721. PubMed ID: 31314613
[No Abstract] [Full Text] [Related]
10. A biopsychosocial approach to improving quality of life in tardive dystonia.
Buscombe C; Alusi SH; Kahn DA
J Psychiatr Pract; 2010 Sep; 16(5):350-7. PubMed ID: 20859113
[TBL] [Abstract][Full Text] [Related]
11. Adverse neurologic effects of metoclopramide.
Grimes JD; Hassan MN; Preston DN
Can Med Assoc J; 1982 Jan; 126(1):23-5. PubMed ID: 7059869
[TBL] [Abstract][Full Text] [Related]
12. Review article: metoclopramide and tardive dyskinesia.
Rao AS; Camilleri M
Aliment Pharmacol Ther; 2010 Jan; 31(1):11-9. PubMed ID: 19886950
[TBL] [Abstract][Full Text] [Related]
13. Chronic metoclopramide therapy for diabetic gastroparesis.
Lata PF; Pigarelli DL
Ann Pharmacother; 2003 Jan; 37(1):122-6. PubMed ID: 12503946
[TBL] [Abstract][Full Text] [Related]
14. Familial acute dystonic-dyskinetic syndrome with dominant inheritance after use of antidopaminergic antiemetic drugs.
Macucci M; Dotti MT; Federico A
Mov Disord; 1995 Jul; 10(4):528-9. PubMed ID: 7565844
[No Abstract] [Full Text] [Related]
15. Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.
Al-Saffar A; Lennernäs H; Hellström PM
Neurogastroenterol Motil; 2019 Nov; 31(11):e13617. PubMed ID: 31050085
[TBL] [Abstract][Full Text] [Related]
16. Metoclopramide: tardive dyskinesia. Beware long-term use.
Prescrire Int; 2009 Oct; 18(103):211. PubMed ID: 19882790
[No Abstract] [Full Text] [Related]
17. The dual role of domperidone in gastroparesis and lactation.
Phan H; DeReese A; Day AJ; Carvalho M
Int J Pharm Compd; 2014; 18(3):203-7. PubMed ID: 25306766
[TBL] [Abstract][Full Text] [Related]
18. Metoclopramide-induced parkinsonism in hemodialysis patients. Report of two cases.
Sirota RA; Kimmel PL; Trichtinger MD; Diamond BF; Stein HD; Yudis M
Arch Intern Med; 1986 Oct; 146(10):2070-1. PubMed ID: 3767555
[TBL] [Abstract][Full Text] [Related]
19. Review article: The diagnosis and management of gastroparesis.
Haans JJ; Masclee AA
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():37-46. PubMed ID: 18081647
[TBL] [Abstract][Full Text] [Related]
20. From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.
Bielefeldt K
Dig Dis Sci; 2017 Nov; 62(11):2999-3013. PubMed ID: 28577245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
